Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.9200 (1.86%) ($100.0900 - $103.1500) on Sat. Sep. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 26 | Latest Price | $101.9200(1.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.18% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $91.68(-10.05%) | Resistance Level | $105.74 | 5 Day Moving Average | $100.21(1.71%) | 10 Day Moving Average | $100.99(0.92%) | 20 Day Moving Average | $105.74(-3.61%) | To recent high | -19.6% | To recent low | 3.1% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |